Among these, USP6 has emerged as a critical regulator in the pathogenesis of diverse malignancies, including pancreatic cancer, aneurysmal bone cysts, breast cancer, nodular fasciitis, cranial fasciitis, colon cancer, and colorectal cancer. This evidence concerns the gene USP6 and breast cancer.